跳至主導覽 跳至搜尋 跳過主要內容

Paradoxical association between steatotic liver disease and favorable hepatic outcomes in HCV patients with SVRs

  • Ming Ling Chang*
  • , Jur Shan Cheng
  • , Jennifer Tai
  • , Wei Ting Chen
  • , Sien Sing Yang
  • , Cherng-Hsun Chiu
  • , Rong Nan Chien
  • , Chia Lin Hsu
  • , Shang Jung Wu
  • , Cathy S.J. Fann*
  • *此作品的通信作者
  • Chang Gung University
  • Chang Gung Memorial Hospital
  • Cathay General Hospital Taiwan
  • Academia Sinica - Institute of Biomedical Sciences

研究成果: 期刊稿件 › 文章 › 同儕審查

1 引文 斯高帕斯(Scopus)

摘要

BACKGROUND: The effects of genetic predispositions and steatotic liver disease (SLD) on the outcomes of chronic hepatitis C (CHC) patients with sustained virological responses (SVRs) remain unknown.

METHODS: A 15-year prospective study of CHC patients with SVRs was conducted.

RESULTS: Among 965 SVR patients, the baseline and 24-week post-HCV therapy SLD rates were 64% and 54%, respectively; the patatin-like phospholipase domain-containing protein 3 (PNPLA3) I148M-rs738409 G allele was negatively correlated with the methylenetetrahydrofolate reductase (MTHFR) C677T Ala222Val-rs1801133 T allele (Pearson's correlation: -0.078, p = 0.025). At baseline, body mass index (BMI) (OR: 1.18; 95% CI: 1.12-1.25), cirrhosis (0.34; 0.20-0.56) and the PNPLA3 G allele (1.28; 1.03-1.60) were associated with SLD. At 24 weeks posttherapy, BMI (1.16; 1.09-1.24), the fibrosis-4 index (0.86; 0.75-0.99), cirrhosis (0.23; 0.14-0.40), HOMA-IR (1.16; 1.04-1.30), the ALT level (1.01; 1.00-1.03) and the MTHFR T allele (0.66; 0.48-0.91) were associated with 24-week SLD in SVR patients. Longitudinally, compared with sex- and age-matched patients without 24-week SLD, patients with 24-week SLD had higher BMIs and ALT levels, poorer metabolic profiles, and greater cumulative incidences of cardiovascular events (70.9% vs. 63.7%, p = 0.026) but lower fibrosis-4 indices and cumulative incidences of cirrhosis (12.7% vs. 31.5%, p < 0.001) and HCC (4.6% vs. 12.1%, p < 0.001). A 24-week SLD was negatively associated with the cumulative incidences of cirrhosis (HR: 0.548; 95% CI HR: 0.281 ~ 0.894) and HCC (0.637; 0.32 ~ 0.99).

CONCLUSIONS: Poorer metabolic profiles and greater cardiovascular but lower hepatic event cumulative incidences were noted in patients with than in those without 24-week SLD. The paradoxical association between SLD and hepatic events might stem from the negative correlation between the PNPLA3 G allele and the MTHFR T allele, which are HCV-specific SLD factors.

原文英語
頁(從 - 到)1347-1359
頁數13
期刊Hepatology International
卷19
發行號6
早期上線日期13 09 2025
DOIs
出版品狀態已出版 - 12 2025

文獻附註

Publisher Copyright:
© Asian Pacific Association for the Study of the Liver 2025.

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG3 健康與福祉
    SDG3 健康與福祉

指紋

深入研究「Paradoxical association between steatotic liver disease and favorable hepatic outcomes in HCV patients with SVRs」主題。共同形成了獨特的指紋。

引用此